KOD insider transaction filings
Kodiak Sciences Inc. — 33 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-17. Screen KOD transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 8 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
Recent Form 4 filings — Kodiak Sciences Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-17 | 4 | PERLROTH VICTOR — Chairman and CEO, Director, 10% owner | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-07-17 | 4 | BORGESON JOHN A. — Chief Financial Officer | Grant/award (A): 66,500 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Dahiyat Bassil I — Director | Grant/award (A): 17,731 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Bancroft Charles A — Director | Grant/award (A): 17,731 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Levy Richard S — Director | Grant/award (A): 17,731 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Yang Taiyin — Director | Grant/award (A): 17,731 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | PROFUSEK ROBERT — Director | Grant/award (A): 17,731 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | BAKER BROS. ADVISORS LP — Director, 10% owner 667, L.P. — Director, 10% owner Baker Bros. Advisors (GP) LLC — Director, 10% owner Baker Brothers Life Sciences LP — Director, 10% owner BAKER FELIX — Director, 10% owner BAKER JULIAN — Director, 10% owner | Grant/award (A): 17,731 (derivative) @ $0 · Grant/award (A): 17,731 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | BORGESON JOHN A. — Chief Financial Officer | Option exercise (M): 30,000 @ $1.04 · Sale (S): 25,896 @ $34.01 · Sale (S): 4,104 @ $34.67 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2026-04-16 | 4 | BORGESON JOHN A. — Chief Financial Officer | Option exercise (M): 28,614 @ $1.04 · Option exercise (M): 28,614 (derivative) @ $0 | EDGAR |
| 2026-04-02 | 4 | BORGESON JOHN A. — Chief Financial Officer | Option exercise (M): 30,000 @ $1.04 · Sale (S): 12,692 @ $39.14 · Sale (S): 12,477 @ $40.29 · Sale (S): 4,231 @ $40.88 · Sale (S): 600 @ $41.77 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2026-03-27 | 4 | PERLROTH VICTOR — Chairman and CEO, Director | Option exercise (M): 300,000 @ $1.04 · Option exercise (M): 300,000 (derivative) @ $0 | EDGAR |
| 2026-03-19 | 4 | PERLROTH VICTOR — Chairman and CEO, Director | Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | BAKER BROS. ADVISORS LP — Director, 10% owner 667, L.P. — Director, 10% owner Baker Bros. Advisors (GP) LLC — Director, 10% owner Baker Brothers Life Sciences LP — Director, 10% owner BAKER FELIX — Director, 10% owner BAKER JULIAN — Director, 10% owner | Purchase (P): 217,428 @ $23 · Purchase (P): 2,391,268 @ $23 | EDGAR |
| 2025-07-08 | 4 | BORGESON JOHN A. — See Remarks | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2025-07-08 | 4 | PERLROTH VICTOR — Chairman and CEO, Director, 10% owner | Grant/award (A): 340,000 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | Bancroft Charles A — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | Dahiyat Bassil I — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | Levy Richard S — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | Yang Taiyin — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | PROFUSEK ROBERT — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | BAKER BROS. ADVISORS LP — Director, 10% owner 667, L.P. — Director, 10% owner Baker Bros. Advisors (GP) LLC — Director, 10% owner Baker Brothers Life Sciences LP — Director, 10% owner BAKER FELIX — Director, 10% owner BAKER JULIAN — Director, 10% owner | Grant/award (A): 40,000 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-06-17 | 4 | BORGESON JOHN A. — See Remarks | Option exercise (M): 1,875 · Sale (S): 723 @ $3.65 · Option exercise (M): 1,875 (derivative) @ $0 | EDGAR |
| 2024-08-07 | 4 | BORGESON JOHN A. — See Remarks | Grant/award (A): 334,500 (derivative) @ $0 | EDGAR |
| 2024-08-07 | 4 | PERLROTH VICTOR — Chairman and CEO, Director, 10% owner | Grant/award (A): 406,000 (derivative) @ $0 | EDGAR |
| 2024-07-02 | 4 | BAKER BROS. ADVISORS LP — Director, 10% owner 667, L.P. — Director, 10% owner Baker Bros. Advisors (GP) LLC — Director, 10% owner Baker Brothers Life Sciences LP — Director, 10% owner BAKER FELIX — Director, 10% owner BAKER JULIAN — Director, 10% owner | Grant/award (A): 40,000 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | Dahiyat Bassil I — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | Bancroft Charles A — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | Levy Richard S — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | Yang Taiyin — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | PROFUSEK ROBERT — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | BORGESON JOHN A. — See Remarks | Option exercise (M): 5,494 · Sale (S): 2,874 @ $2.75 · Option exercise (M): 3,619 (derivative) @ $0 · Option exercise (M): 1,875 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | BORGESON JOHN A. — See Remarks | Option exercise (M): 3,025 · Sale (S): 1,558 @ $2.92 · Option exercise (M): 3,025 (derivative) @ $0 | EDGAR |
Recent 8-K events — Kodiak Sciences Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-04 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-31 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-27 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-18 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-03 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-05-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=KOD returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →